These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
343 related items for PubMed ID: 18162932
21. Improvements in subcutaneous fat, lipid profile, and parameters of mitochondrial toxicity in patients with peripheral lipoatrophy when stavudine is switched to tenofovir (LIPOTEST study). Ribera E, Paradiñeiro JC, Curran A, Sauleda S, García-Arumí E, Castella E, Puiggròs C, Crespo M, Feijoo M, Diaz M, Del Saz SV, Planas M, Sureda D, Falcó V, Ocaña I, Pahissa A. HIV Clin Trials; 2008; 9(6):407-17. PubMed ID: 19203906 [Abstract] [Full Text] [Related]
22. Mitochondrial effects of antiretroviral therapies in asymptomatic patients. López S, Miró O, Martínez E, Pedrol E, Rodríguez-Santiago B, Milinkovic A, Soler A, García-Viejo MA, Nunes V, Casademont J, Gatell JM, Cardellach F. Antivir Ther; 2004 Feb; 9(1):47-55. PubMed ID: 15040536 [Abstract] [Full Text] [Related]
25. The role of nucleoside and nucleotide analogues in nodular regenerative hyperplasia in HIV-infected patients: a case control study. Cotte L, Bénet T, Billioud C, Miailhes P, Scoazec JY, Ferry T, Brochier C, Boibieux A, Vanhems P, Chevallier M, Zoulim F. J Hepatol; 2011 Mar 15; 54(3):489-96. PubMed ID: 21056493 [Abstract] [Full Text] [Related]
27. Distinct mechanisms for mitochondrial DNA loss in T and B lymphocytes from HIV-infected patients exposed to nucleoside reverse-transcriptase inhibitors and those naive to antiretroviral treatment. Maagaard A, Holberg-Petersen M, Løvgården G, Holm M, Pettersen FO, Kvale D. J Infect Dis; 2008 Nov 15; 198(10):1474-81. PubMed ID: 18851688 [Abstract] [Full Text] [Related]
29. Mitochondrial assessment in asymptomatic HIV-infected paediatric patients on HAART. Morén C, Noguera-Julian A, Rovira N, Garrabou G, Nicolàs M, Cardellach F, Martínez E, Sánchez E, Miró O, Fortuny C. Antivir Ther; 2011 Nov 15; 16(5):719-24. PubMed ID: 21817193 [Abstract] [Full Text] [Related]
30. Thyroid function in human immunodeficiency virus patients treated with highly active antiretroviral therapy (HAART): a longitudinal study. Madeddu G, Spanu A, Chessa F, Calia GM, Lovigu C, Solinas P, Mannazzu M, Falchi A, Mura MS, Madeddu G. Clin Endocrinol (Oxf); 2006 Apr 15; 64(4):375-83. PubMed ID: 16584508 [Abstract] [Full Text] [Related]
31. Metabolic benefits of switching to tenofovir/lamivudine after long-term use of stavudine/lamivudine in NNRTI-based antiretroviral regimens: a prospective study. Manosuthi W, Lueangniyomkul A, Mankatitham W, Chimsuntorn S, Tantanathip P, Thongyen S, Suntisuklappon B, Nilkamhang S, Sungkanuparph S. J Infect; 2011 May 15; 62(5):406-9. PubMed ID: 21382413 [No Abstract] [Full Text] [Related]
40. Tenofovir: what have over 1 million years of patient experience taught us? Pozniak A. Int J Clin Pract; 2008 Aug 15; 62(8):1285-93. PubMed ID: 18705824 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]